‘Pharma Bro’ Shkreli was shady – and profitable, investors testify

Shkreli

The jury at the securities fraud trial of “Pharma Bro” Martin Shkreli has heard investors accuse the quirky former biotech CEO of repeatedly giving them the runaround when they tried to pull their money out of his failing health care hedge fund.